Medicine can’t work when it’s not taken

Medication sitting unused in the cabinet doesn’t do any good – from the forgetful patient, to the pharmacist, to the precribing physician, back to the pharma company that developed it. Medisafe is a complete continuum-of-care solution providing peace of mind to millions of users while helping to solve the $300 billion medication non-adherence problem.

  • For patients: When is my next pill? We get it. Everyone needs some encouragement to sustain a new behavior. Medisafe gets people started by educating them about their meds and condition, then keeps them going by sharing progress, offering helpful tips, and curating tailored prescription coupons and special offer. Explore all features
  • For physicians: How is my patient doing? Physicians can simply invite their patients to connect through Medisafe and adherence info as well as other health data is automatically brought into their dashboard. Join Medisafe Providers
  • For partners: How can I reach my customers? Medisafe goes way beyond the pill. We work with pharma, payors and others who share our passion for creating better patient outcomes through increased adherence. Learn how

Join us in solving for the healthcare triple aim

Our approach to solving non-adherence sits squarely in the middle of the Healthcare Triple Aim Triangle.

Explore all our solutions

Patient Experience Medisafe empowers people to take control of their health and provides peace-of-mind through a personalized, interactive experience that saves time, frustration and money.

Population Health Medisafe has logged billions of data points related to adherence that provides detailed insights into disease state, demographics, and more.

Controlling Costs Medisafe helps partners manage risk and improve outcomes with real-time data on patient adherence patterns.

Our Featured Partners

Proven solutions tailored for business

Become our partner

Medisafe's Impact on Adherence

Medisafe users with hypertension and hyperlipidemia have significantly higher medication persistence than a matched control group.

+10.3%

hypertension

+19.5%

hyperlipemia

+17%

Adherence improvement for users who add a Medisafe caregiver

-13mmHG

Reduction in systolic blood pressure within 30 days

60%

of Stage 2 hypertensive users dropped to Stage 1 or better levels

Research highlights

Medisafe delivers high rates of adherence now and beyond the first fill - no matter how complex the dosing. We can prove it.

All our research studies